RAC 4.32% $1.55 race oncology ltd

AML still worth $1b and significantly derisked + orphan drug...

  1. 2,710 Posts.
    lightbulb Created with Sketch. 2824
    AML still worth $1b and significantly derisked + orphan drug exclusivity. I would favour a CR ahead of dropping one program to fund another.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.